Recent research reports in the United States and Canada have called encouraging results of the use of the experimental drug Remdesivir for people with the new Novel Corona virus disease Code 19

Recent research reports in the United States and Canada have called encouraging results of the use of the experimental drug Remdesivir for people with the new Novel Corona virus disease Code 19.
Now the expectations about this experimental drug have increased even further when it was reported in a reliable US health website that the patients using the remodeled cancer recovered quickly and returned home within a few days.

The effects of this anti-viral drug developed by Gilead Signs during a trial in a Chicago hospital were closely monitored on patients.

The results showed that the patients used fever and respiratory symptoms very quickly, and in less than a week, all patients were declared as doctors and discharged from the hospital.
125 patients at Cody 19 at the University of Chicago Medicine were included in the third phase of the pharmaceutical company's clinical trials.

113 out of 125 people had a high severity of the disease, and for the treatment of all these patients, the remodeled fluid was injected daily into the body by injection.
The good news is that most of our patients are discharged now, only 2 patients are left, said Dr. Kathleen Mullin, an epidemiologist at the University of Chicago and who oversees the study of this experimental drug.

Clinical trials are underway in various countries regarding this experimental drug, which is evaluating its efficacy against cod 19, especially in China, the results of a major study may be unveiled sometime this month.

At this point, all we can say is that we are looking forward to the results of ongoing studies around the world,  Gilead said in a statement citing research from the University of Chicago.
The company said the results of clinical trials on its serious Cod-19 cases may be revealed in April, and according to University of Chicago physician Kathleen Moline, Gilead has locked data on a separate study of 400 patients, May be released at any time.

Dr Kathleen avoided making any clear conclusions, saying, "This is very difficult, because the study did not compare to other drug use groups, but when we started using the drug, we saw That the severity of the fever started to diminish, we saw that when the patient came in with a high fever, this medication would reduce it immediately, we saw people coming out of ventilators the day after treatment, so overall. This medicine worked very well on our patients'.

Most of our patients had a high severity of the disease and most of them were discharged within 6 days, so we can say that the duration of treatment was not 10 days, very few patients, maybe 3 people," he said. Who were discharged in 10 days.
In fact, increasing the severity of the disease increases the risk of mortality in Cod 19 patients, so it is truly surprising for 113 such patients to be discharged so quickly.

Serious cases of GLAAD have involved 244 patients in 152 different clinical trials worldwide, while separate trials are being performed on 166 moderate patients in 169 different centers.
These trials are investigating 5- and 10-day drug treatment courses, and the main objective is to see which of the two courses is most effective for patients.

The report also mentions a patient who was part of the Chicago University study.

Salomeir, 57, is a minor factory worker in Chicago, and one of his daughters became ill at the end of March and was later diagnosed with Cody 19.

After that, the questioner also complained of high fever, difficulty breathing and severe back pain and said, 'I felt like someone was punching my lungs'.
At the urging of his wife, he went to the University of Chicago Medicine Hospital on April 3, at which time the fever had reached 104 and breathing was difficult.

They were given oxygen there and, with their permission, were included in experimental drug trials.
On April 4, for the first time, they were using a remodecore, 'my

fever almost immediately went away and I started to feel better'.
He was discharged with oxygen after the second dose on Sunday, and after two more days of using the drug, the condition improved so much that he was discharged from the hospital on April 7.
In his own words, 'Remediors is a charisma'.
And the world is desperate to find out if this drug really has a charismatic effect on the outbreak.